|
Market Closed -
Australian S.E.
10:10:26 18/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.2450 AUD | -2.00% |
|
0.00% | -27.94% |
| 09-15 | Paradigm Biopharmaceuticals Names Chief Medical Officer | MT |
| 09-11 | Paradigm Biopharmaceuticals Draws Down Final $2 Million of Tranche 4 From Convertible Note Facility; Shares Down 13% | MT |
Chart: Technical Analysis
Australian S.E.AUD
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| PAR | Delayed | |
OTC Markets
| PBIGF | Delayed | |
Deutsche Boerse AG
| P86 | Delayed | |
Börse Stuttgart
| P86 | Delayed | |
Tradegate
| P86 | Real-time | |
Boerse Muenchen
| P86 | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Neutral |
| Resistance | 0.285 | 0.285 | 0.435 |
| Spread/Res. | -14.04% | -14.04% | -43.68% |
| Spread/Supp. | +8.89% | +28.95% | +68.97% |
| Support | 0.225 | 0.19 | 0.145 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- PAR Stock
- Charts Paradigm Biopharmaceuticals Limited
Select your edition
All financial news and data tailored to specific country editions

















